Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-04-032075
Filing Date
2004-06-21
Accepted
2004-06-21 16:39:39
Documents
2
Period of Report
2004-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6304
2 POA DOCUMENT poa.txt EX-24.4_46569 1700
  Complete submission text file 0001209191-04-032075.txt   10058
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Issuer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O OSI PHARMACEUTICALS, INC. 58 S. SERVICE ROAD, SUITE 110 MELVILLE NY 11747
Business Address 631-962-2000
PINEDO HERBERT MD PHD (Reporting) CIK: 0001293196 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15190 | Film No.: 04872884